2014

Acquisition of Steinway Musical Instruments, Inc. by Kohlberg & Company May Not Be in the Best Interests of Steinway Shareholders

SAN DIEGO and WALTHAM, Mass., July 1, 2013 /PRNewswire/ -- Shareholder rights attorneys at Robbins Arroyo LLP are investigating the acquisition of Steinway Musical Instruments, Inc. (NYSE: LVB) ("Steinway") by Kohlberg & Company ("Kohlberg"), a global private equity investment firm.  On July 1, 2013, Steinway announced that it has entered into a definitive agreement with Kohlberg in which Kohlberg will commence a tender offer to acquire all of the outstanding shares of Steinway's common stock for $35.00 per share in cash.

(Logo:  http://photos.prnewswire.com/prnh/20130103/MM36754LOGO)

Is the Acquisition Best for Steinway and Its Shareholders?

Robbins Arroyo LLP's investigation focuses on whether the board of directors at Steinway is undertaking a fair process to obtain maximum value and adequately compensate its shareholders in the merger.  The $35.00 merger consideration represents a premium of only 15.2% based on Steinway's closing price on June 28, 2013, the last trading day prior to the acquisition announcement.  The 15.2% premium is substantially below the median premium of 29.70% for comparable transactions in the past five years.

On May 5, 2013, Steinway released financial results for the first quarter of its fiscal year 2013, reporting net income of $2.7 million for the 2013 period compared to $0.06 million for the prior-year period.  Specific to its piano and band operations, Steinway reported that: (i) piano operations' first quarter revenue totaled $45.4 million, a 2.9% increase over the prior-year quarter; and (ii) sales of higher-margin instruments, coupled with price increases, led to band operations' exceptional gross margin improvement of 600 basis points over the first quarter of 2012.

In response to these results, Chief Executive Officer Michael Sweeney noted that "first-quarter results demonstrate significant improvement in [the company's] profitability profile."  Mr. Sweeney concluded, "We see an exciting path to growth for our Company. The steps we took in mid-2012 to ramp up Steinway grand piano production will soon enable us to realize even more fully the operating leverage inherent in our business."

Given these facts, the firm is examining Steinway's board of directors' decision to be acquired by Kohlberg now rather than allow shareholders to continue to participate in the company's continued success and future growth prospects.   

Steinway shareholders have the option to file a class action lawsuit to secure the best possible price for shareholders and the disclosure of material information to shareholders.  Steinway shareholders interested in information about their rights and potential remedies can contact Darnell R. Donahue at (800) 350-6003, ddonahue@robbinsarroyo.com, or via the shareholder information form on the firm's website.

Robbins Arroyo LLP is a nationally recognized leader in securities litigation and shareholder rights law.  The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested.  For more information, please go to http://www.robbinsarroyo.com.

Press release link: http://www.robbinsarroyo.com/shareholders-rights-blog/steinway-musical-instruments/

Attorney Advertising.Past results do not guarantee a similar outcome.  

Contact:
Darnell R. Donahue
Robbins Arroyo LLP
ddonahue@robbinsarroyo.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsarroyo.com

SOURCE Robbins Arroyo LLP



RELATED LINKS
http://www.robbinsarroyo.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.